acitretin has been researched along with Adenocarcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Aung, PP; Cho, WC; Curry, JL; Gill, P; Heberton, M; Murphy, MB; Nagarajan, P; Nikolaou, V; Om, A; Patel, AB; Ruiz-Bañobre, J; Seervai, RNH; Torres-Cabala, CA; Yamamoto, T | 1 |
Chen, Z; Wu, JH; Zhang, X; Zhao, J | 1 |
Hertel, K; Höffken, K; Kloos, C; Metzner, U; Müller, UA; Raabe, G; Schreiber, J | 1 |
3 other study(ies) available for acitretin and Adenocarcinoma
Article | Year |
---|---|
Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma.
Topics: Acitretin; Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Humans; Middle Aged; Nivolumab; Psoriasis | 2022 |
Case Report: Bazex Syndrome Associated With Pulmonary Adenocarcinoma.
Topics: Acitretin; Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Biopsy, Needle; Bone Neoplasms; Carcinoma, Basal Cell; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Gefitinib; Humans; Hypotrichosis; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Male; Paraneoplastic Syndromes; Quinazolines; Radiography; Rare Diseases; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2016 |
[Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary].
Topics: Acitretin; Adenocarcinoma; Aged; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Keratolytic Agents; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Pityriasis Rubra Pilaris; Prednisolone; Skin | 2002 |